New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
10:55 EDTIDRA, IDRASummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Idera's (IDRA) toll-like receptor antagonist (IMO-8400) for Psoriasis on an Analyst/Industry conference call to be held on March 14 at 11 am.
News For IDRA From The Last 14 Days
Check below for free stories on IDRA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 12, 2014
07:36 EDTIDRAIdera Pharmaceuticals says 'well capitalized' to execute current business goals
Subscribe for More Information
07:31 EDTIDRAIdera Pharmaceuticals reports Q2 EPS (10c), consensus (9c)
Subscribe for More Information
August 7, 2014
08:14 EDTIDRAIdera Pharmaceuticals announces collaboration with TMA
Subscribe for More Information
August 6, 2014
08:21 EDTIDRAIdera Pharmaceuticals announces GSOs publication
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use